FDA Adverse Event Malfunction Summary report: N

INFUSOR

MDR report key: 10270832 · Received July 14, 2020

Report

Report Number
1416980-2020-03970
Event Type
Malfunction
Date Received
July 14, 2020
Date of Event
June 19, 2020
Report Date
August 18, 2020
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
MEB
UDI-DI
00085412081366
PMA / PMN Number
K071222
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 0

CORRECTION MADE TO G5: PMA/510K #: K071222 (PREVIOUSLY NA). ADDITIONAL INFORMATION WAS ADDED TO H4 AND H6. H4: THE LOT WAS MANUFACTURED FROM NOVEMBER 25, 2019 - NOVEMBER 26, 2019. H10: A BATCH REVIEW WAS CONDUCTED AND THERE WERE NO DEVIATIONS FOUND RELATED TO THIS REPORTED CONDITION DURING THE MANUFACTURE OF THIS LOT. THE DEVICE WAS NOT RECEIVED FOR EVALUATION; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(6). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A LARGE VOLUME INFUSOR UNDER INFUSED. IT WAS FURTHER REPORTED APPROXIMATELY 30 - 40% OF THE SOLUTION REMAINED IN THE DEVICE. THE DEVICE HAD BEEN FILLED WITH 18000MG PIPERACILLIN / TAZOBACTAM DILUTED IN 0.9% SODIUM CHLORIDE AND WAS INFUSED VIA A PICC (PERIPHERALLY INSERTED CENTRAL CATHETER).. THERE WAS NO REPORT OF PATIENT INJURY OR MEDICAL INTERVENTION ASSOCIATED WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
733888 INFUSOR PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE CORPORATION NA 19M041 00085412081366

Patients

Seq Age Sex Outcome Treatment
1 PICC LINE| PIPERACILLIN / TAZOBACTAM 18000MG| SODIUM CHLORIDE 0.9%| PICC LINE| PIPERACILLIN / TAZOBACTAM 18000MG| SODIUM CHLORIDE 0.9%